| Financial Year |
March 31 2023 |
| Monetary Funds |
828,878,868.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
197,344,180.29 |
| Accounts Receivable |
756,153,995.47 |
| Advances to Suppliers |
123,068,876.53 |
| Other Receivables |
51,363,675.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,110,821,008.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
44,763,219.54 |
| Total Current Assets |
3,208,623,754.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
25,605,527.99 |
| Long-term Equity Investment |
2,266,474.16 |
| Investment Properties |
-- |
| Fixed Assetes |
277,843,782.71 |
| Under-construction Projects |
642,801.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
82,839,443.47 |
| R&D expenses |
-- |
| Goodwill |
5,900.64 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
96,489,906.10 |
| Other Non-Current Assets |
6,424,858.37 |
| Sub-Total of Non-Current Assets |
499,505,769.61 |
| Total Assets |
3,708,129,524.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
307,889,994.41 |
| Accounts Payable |
692,637,640.47 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,189,162.61 |
| Taxes Payable |
18,235,208.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
83,061,246.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
100,196,805.57 |
| Other Current Liabilities |
8,204,539.04 |
| Sub-Total of Current Liabilities |
1,879,548,924.04 |
| Long-term Loans |
100,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
44,422,945.81 |
| Special Payable |
-- |
| Estimatied Liabilities |
94,499,757.87 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
312,439,156.30 |
| Total Liabilities |
2,191,988,080.34 |
| Paid-In Capital(Or Share Stock) |
170,000,000.00 |
| Capital Surplus |
403,931,070.93 |
| Surplus Reserve |
498,130,310.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
322,203,121.97 |
| Minority Stockholder's Interest |
111,476,351.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,404,665,092.17 |
| Owner's Equity（Stockholder's Equity） |
1,516,141,444.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,708,129,524.40 |
